20 articles
Natural Monarda didyma supplement tested in 81-person study for anti-aging effects. Results could reshape longevity strategies.
Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.
A completed trial tests whether daily Nordic berry beverages can sharpen cognition in healthy adults over 12 weeks.
Novel KH-1 supplement containing spermidine and probiotics tested for autophagy stimulation and glucose control in 42 prediabetic participants.
Phase 3 trial of IBI306, a PCSK9 inhibitor, tests LDL-C reduction in Chinese adults with high cardiovascular risk on statin therapy.
UCSF study reveals how metformin and trimethoprim interfere with thiamine uptake, potentially affecting energy metabolism.
Small trial explores how amiloride improves oxygen delivery to heart muscle by enhancing potassium transport in red blood cells.
A Phase 2 trial tests whether a fixed-dose combination pill can safely lower LDL cholesterol in people with type 2 diabetes.
246-person study tested whether inulin fiber from Jerusalem artichokes could help prediabetic patients return to normal blood sugar levels.
The EPICURO trial tests MERIVA® turmeric over 6 months to see if it protects cognition in adults with metabolic syndrome.
Probucol, a discontinued cholesterol medication, may boost brain-protective proteins in older adults at risk for dementia.
Small trial tests whether dasatinib plus quercetin can improve brain blood flow and cognition in at-risk older adults.
Singapore trial tests ancient herbal remedy against placebo for hormone-related dry eye in 150 postmenopausal women.
58-person trial compared resveratrol's effects to calorie restriction on insulin sensitivity, gene expression, and cardiovascular markers.
Large 7-year study tested whether Ginkgo biloba extract could slow progression from memory complaints to dementia in nearly 3,000 adults.
A Phase 1/2 trial tests whether nicotinamide riboside can restore NAD+ balance and improve heart function in systolic HF patients.
Clinical trial tests whether senolytic compounds can reduce cellular aging burden and improve bone health markers in older adults.
First major clinical trial tests whether resveratrol, found in red wine, can slow Alzheimer's progression through sirtuin activation.
A Phase 2 pilot trial investigates whether the natural senolytic compound fisetin can reduce dysfunction and complications in COVID-19 patients.
A completed Phase 4 trial from India evaluates whether ALA supplementation boosts flunarizine's migraine-prevention power in adolescents.
